Physician profile
Kirit S Patel
NPI 1891727087
$4,265.00
in general payments reported to CMS, 2019-2025
21 companies · $208 in 2025
The $208 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,443 · 2020: $1,520 · 2021: $342 · 2022: $451 · 2023: $270 · 2024: $32.60 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $392 · Education: $118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $391.79 |
| Education | $118.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celularity INC. | $2,700.00 | 2019-2022 | |
| Medtronic Vascular, INC. | $597.11 | 2020 | |
| Abbvie INC. | $263.82 | 2019-2023 | |
| Astellas Pharma US INC | $154.11 | 2023-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $119.88 | 2023-2025 | Myfembree |
| Allergan, INC. | $60.13 | 2019 | |
| Organon LLC | $50.55 | 2023-2025 | Jada System |
| Myovant Sciences INC. | $46.17 | 2022 | |
| Vertical Pharmaceuticals, LLC | $40.69 | 2019 | |
| Hologic Sales and Service, LLC | $40.24 | 2021-2025 | Fluent Fluid Management System, Myosure Tissue Removal Device |
| Medtronic, INC. | $26.71 | 2025 | Truclear |
| Avion Pharmaceuticals | $23.15 | 2020-2022 | |
| Pfizer INC. | $19.27 | 2023 | |
| Meditrina | $17.88 | 2025 | |
| Dexcom, INC. | $17.34 | 2025 | Dexcom G6 Transmitter |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $16.69 | 2024 | |
| Shield Therapeutics INC | $16.31 | 2025 | |
| Therapeuticsmd, INC. | $15.85 | 2021 | |
| Ethicon US, LLC | $14.82 | 2019 | |
| Coopersurgical, INC. | $12.88 | 2023 | Paragard T 380a |
| Exeltis, USA INC. | $11.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kirit Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.